Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Gu · SciRah

Researcher profile · Semantic Scholar

A. Gu

Share profile

A. Gu — researcher profile on SciRah

h-index: 20
Works: 95
Citations: 1,539

Most-cited papers

MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN
Tao Yu, Lei Liu, Jing Li, Mingxia Yan +6 more
2015OncoTarget143 citations Open access
Semantic Scholar
Upregulated lncRNA-UCA1 contributes to progression of lung cancer and is closely related to clinical diagnosis as a predictive biomarker in plasma.
Hui-Min Wang, Jian-Hong Lu, Wen-Yi Chen, A. Gu
2015International Journal of Clinical and Experimental Medicine121 citations
Semantic Scholar
Combination of chemotherapy and gefitinib as first‐line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial
Bao-Hui Han, Bo Jin, T. Chu, Y. Niu +12 more
2017International Journal of Cancer117 citations Open access
Semantic Scholar
Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation‐Positive Non‐Small Cell Lung Cancer: A Prospective, Single‐Arm, Phase II Study
Li-Wen Xiong, Rong Li, Jia-Yuan Sun, Y. Lou +16 more
2018The Oncologist109 citations Open access
Semantic Scholar
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or with Endostar for Advanced Non-small Cell Lung Cancer
Bao-Hui Han, Q. Xiu, Hui-Min Wang, Jie Shen +11 more
2011Journal of Thoracic Oncology87 citations Open access
Semantic Scholar
The Value of Autofluorescence Bronchoscopy Combined with White Light Bronchoscopy Compared with White Light Alone in the Diagnosis of Intraepithelial Neoplasia and Invasive Lung Cancer: A Meta-Analysis
Jia-Yuan Sun, D. Garfield, B. Lam, Jing-jing Yan +3 more
2011Journal of Thoracic Oncology73 citations Open access
Semantic Scholar
Comparing Nanoparticle Polymeric Micellar Paclitaxel and Solvent-based Paclitaxel as First-line Treatment of Advanced Non-Small Cell Lung Cancer: An Open-label, Randomized, Multicenter, Phase III Trial.
M. Shi, A. Gu, H. Tu, Cheng Huang +26 more
2020Annals of Oncology66 citations Open access
Semantic Scholar
A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC).
Xing-Sheng Hu, Bao-Hui Han, A. Gu, Yi-Ping Zhang +16 more
2014Lung Cancer54 citations
Semantic Scholar
Association of XPD Polymorphisms with Severe Toxicity in Non–Small Cell Lung Cancer Patients in a Chinese Population
Wen-Ting Wu, Wei Zhang, R. Qiao, Dan Chen +11 more
2009Clinical Cancer Research54 citations Open access
Semantic Scholar
Co-expression IL-15 receptor alpha with IL-15 reduces toxicity via limiting IL-15 systemic exposure during CAR-T immunotherapy
Ying Zhang, Q. Zhuang, Fang Wang, Can Zhang +5 more
2022Journal of Translational Medicine42 citations Open access
Semantic Scholar
Role of miR-497 in VEGF-A-mediated cancer cell growth and invasion in non-small cell lung cancer.
A. Gu, Jianhong Lu, Weimin Wang, C. Shi +2 more
2016International Journal of Biochemistry and Cell Biology42 citations
Semantic Scholar
SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC.
Fang-lin Zhang, Hechun Lin, A. Gu, Jing Li +7 more
2014Journal of Proteomics41 citations
Semantic Scholar
Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients
Li-Wen Xiong, Y. Lou, H. Bai, Rong Li +8 more
2019Journal of International Medical Research39 citations Open access
Semantic Scholar
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
Jun Lu, H. Zhong, Jun Wu, T. Chu +20 more
2019Advancement of science31 citations Open access
Semantic Scholar
Hsa‐miR‐196a2 Functional SNP is Associated With Severe Toxicity After Platinum‐Based Chemotherapy of Advanced Nonsmall Cell Lung Cancer Patients in a Chinese Population
Xiao-Ying Zhan, Wen-Ting Wu, Bao-Hui Han, G. Gao +11 more
2012Journal of clinical laboratory analysis (Print)30 citations Open access
Semantic Scholar
XRCC1 genetic polymorphisms and sensitivity to platinum-based drugs in non-small cell lung cancer: an update meta-analysis based on 4708 subjects.
A. Gu, Weimin Wang, Wen-Yi Chen, C. Shi +2 more
2015International Journal of Clinical and Experimental Medicine27 citations
Semantic Scholar
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung Cancer.
Jian-Lin Xu, T. Chu, Bo Jin, Xue Dong +11 more
2016Clinical Lung Cancer25 citations
Semantic Scholar
China experts consensus on icotinib for non-small cell lung cancer treatment (2015 version).
Yuan-Kai Shi, Yan Sun, C. Ding, Zi-Ping Wang +27 more
2015Journal of Thoracic Disease24 citations
Semantic Scholar
Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients
Li-Wen Xiong, S. Cui, Jingyan Ding, Yun Sun +11 more
2017OncoTarget22 citations Open access
Semantic Scholar
Is there a progression‐free survival benefit of first‐line crizotinib versus standard chemotherapy and second‐line crizotinib in ALK‐positive advanced lung adenocarcinoma? A retrospective study of Chinese patients
S. Cui, Yi-Zhuo Zhao, Lili Dong, A. Gu +6 more
2016Cancer Medicine21 citations Open access
Semantic Scholar
Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial
Qing Xia, Guo-Jie Chen, Yan-bei Ren, Tiansheng Zheng +9 more
2021BMC Cancer20 citations Open access
Semantic Scholar
Use of SuperARMS EGFR Mutation Detection Kit to Detect EGFR in Plasma Cell‐free DNA of Patients With Lung Adenocarcinoma
S. Cui, Lin Ye, Hui-Min Wang, T. Chu +5 more
2017Clinical Lung Cancer20 citations
Semantic Scholar
Polymeric micellar paclitaxel (Pm-Pac) prolonged overall survival for NSCLC patients without pleural metastasis.
Jun Lu, A. Gu, Weimin Wang, Ai-Mi Huang +2 more
2022International journal of pharmaceutics19 citations
Semantic Scholar
Whole-Exome Sequencing on Circulating Tumor Cells Explores Platinum-Drug Resistance Mutations in Advanced Non-small Cell Lung Cancer
Yuan-Yuan Chang, Yin Wang, Boyi Li, Xingzhong Lu +8 more
2021Frontiers in Genetics19 citations Open access
Semantic Scholar
Efficacy and tolerability of crizotinib in the treatment of ALK-positive, advanced non-small cell lung cancer in Chinese patients
S. Cui, Yi-Zhuo Zhao, A. Gu, Xiaoxiao Ge +6 more
2015Medical Oncology18 citations
Semantic Scholar
Efficacy and safety of first-line anlotinib-based combinations for advanced non-small cell lung cancer: a three-armed prospective study
T. Chu, Wei Zhang, Bo Zhang, R. Zhong +21 more
2022Translational Lung Cancer Research17 citations Open access
Semantic Scholar
Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
Yi Jiang, Ling-Shuang Liu, Li-Ping Shen, Jiaxiang Liu +6 more
2019Clinical Lung Cancer17 citations
Semantic Scholar
Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer.
A. Gu, C. Shi, Li-Wen Xiong, T. Chu +2 more
2013Chinese journal of cancer research = Chung-kuo yen cheng yen chiu17 citations
Semantic Scholar
IL13Rα2-targeted third-generation CAR-T cells with CD28 transmembrane domain mediate the best anti-glioblastoma efficacy
A. Gu, Yue Bai, Can Zhang, Chang Xu +5 more
2023Cancer Immunology and Immunotherapy16 citations Open access
Semantic Scholar
Can Determination of Circulating Endothelial Cells and Serum Caspase-Cleaved CK18 Predict for Response and Survival in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Endostatin and Paclitaxel–Carboplatin Chemotherapy? A Retrospective Study
T. Chu, H. Ding, D. Garfield, A. Gu +3 more
2012Journal of Thoracic Oncology16 citations Open access
Semantic Scholar
[A multicenter, randomized, double-blind, placebo-controlled safety study to evaluate the clinical effects and quality of life of paclitaxel-carboplatin (PC) alone or combined with endostar for advanced non-small cell lung cancer (NSCLC)].
Bao-Hui Han, Q. Xiu, Hui-Min Wang, Jie Shen +13 more
2011Zhonghua zhong liu za zhi [Chinese journal of oncology]16 citations
Semantic Scholar
Survival analysis for lung adenosquamous carcinoma patients with brain metastasis
F. Pan, S. Cui, Weimin Wang, A. Gu +1 more
2018Journal of Cancer13 citations Open access
Semantic Scholar
Role of endobronchial ultrasound‐guided transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma: Experience of a single institution in China
Jia-Yuan Sun, Jian Zhang, Heng Zhao, Jie Shen +2 more
2010Thoracic Cancer13 citations
Semantic Scholar
Factors that predict progression-free survival in Chinese lung adenocarcinoma patients treated with epidermal growth factor receptor tyrosine kinase inhibitors.
S. Cui, Li-Wen Xiong, Y. Lou, Huangping Shi +7 more
2016Journal of Thoracic Disease12 citations
Semantic Scholar
Expert consensus on multi-disciplinary treatment, whole-course pulmonary rehabilitation management in patients with lung cancer and chronic obstructive lung disease.
X. Mao, F. Hu, Jin Peng, Yi-Zhuo Zhao +19 more
2022Annals of Palliative Medicine11 citations Open access
Semantic Scholar
中国埃克替尼治疗非小细胞肺癌专家共识（2016年版）
Yuan-Kai Shi, Yan Sun, C. Ding, Zi-Ping Wang +26 more
2016Zhongguo fei ai za zhi = Chinese journal of lung cancer11 citations
Semantic Scholar
NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis
Y. Lou, Rong Li, Li-Wen Xiong, A. Gu +7 more
2013Tumor Biology10 citations
Semantic Scholar
ERCC1 protein as a guide for individualized therapy of late-stage advanced non-small cell lung cancer.
Zhiqiang Gao, Bao-Hui Han, Jie Shen, A. Gu +8 more
2011Experimental and Therapeutic Medicine10 citations Open access
Semantic Scholar
Feasibility of continuing crizotinib therapy after RECIST-PD in advanced non-small cell lung cancer patients with ALK/ROS-1 mutations
Jun Liu, S. Cui, F. Pan, Yi-Qian Ni +6 more
2018Journal of Cancer8 citations Open access
Semantic Scholar
中国埃克替尼治疗非小细胞肺癌专家共识(2015版)
Yuan-Kai Shi, Yan Sun, C. Ding, Zi-Ping Wang +27 more
2015Zhongguo fei ai za zhi = Chinese journal of lung cancer8 citations
Semantic Scholar
Safety and efficacy results of a phase IV, open-label, multicenter, safety-monitoring study of icotinib in treating advanced non-small cell lung cancer (NSCLC): ISAFE study.
F. Tan, A. Gu, Yi-Ping Zhang, S. Jiao +16 more
20136 citations
Semantic Scholar
Clinical observation of gefitinib as a first-line therapy in sixty-eight patients with advanced NSCLC.
Zhiqiang Gao, Bao-Hui Han, Hui-Min Wang, C. Shi +2 more
2012Oncology Letters6 citations Open access
Semantic Scholar
Efficacy, safety, and prognostic factors of anlotinib treatment in advanced non-small cell lung cancer patients
Ai-Mi Huang, Weimin Wang, Ruoyan Qin, Guo-Jie Chen +2 more
2022Journal of Cancer Research and Therapeutics5 citations Open access
Semantic Scholar
Low NDRG2 expression predicts poor prognosis in solid tumors
A. Gu, Jie Xu, Jun Ye, Chuan-Meng Zhang
2020Medicine5 citations Open access
Semantic Scholar
Analysis of the clinical effect of osimertinib on 90 cases with advanced lung adenocarcinoma
Zhiqiang Gao, Weimin Wang, A. Gu, Jianhong Lu +5 more
2020Translational Lung Cancer Research5 citations Open access
Semantic Scholar
P1.01-95 Efficacy and Safety of Anlotinib in Combination with Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Bao-Hui Han, T. Chu, Xiaojun Zhang, H. Zhong +6 more
2019Journal of Thoracic Oncology5 citations Open access
Semantic Scholar
Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: a prospective and single arm study (DANCE study)
Bo Zhang, C. Shi, Zhiqiang Gao, H. Zhong +9 more
2022BMC Cancer4 citations Open access
Semantic Scholar
Afatinib 30 mg in the treatment of common and uncommon EGFR-mutated advanced lung adenocarcinomas: a retrospective, single-center, longitudinal study
J. Qian, Xuanting Ye, Ai-Mi Huang, Ruoyan Qin +6 more
2021Journal of Thoracic Disease4 citations Open access
Semantic Scholar
Efficacy and safety analysis of anlotinib combined with PD-1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study
Xuanting Ye, Ai-Mi Huang, Yan Zhou, Yanbin Kuang +3 more
2023Journal of Thoracic Disease3 citations Open access
Semantic Scholar
Efficacy, safety and prognostic factors analysis of first-line icotinib treatment in advanced non-small cell lung cancer patients with mutated EGFR
Ai-Mi Huang, Q. Shen, Xiao-Lu Yu, Hui-Min Wang +3 more
2018Translational Cancer Research3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Bao-Hui Han×24
Invite
Bao-Hui Han — researcher profile on SciRah
C. Shi×17
Invite
C. Shi — researcher profile on SciRah
Li-Wen Xiong×17
Invite
Li-Wen Xiong — researcher profile on SciRah
Hui-Min Wang×15
Invite
Hui-Min Wang — researcher profile on SciRah

×14

Invite

Li-Yan Jiang — researcher profile on SciRah

Invite

T. Chu — researcher profile on SciRah

Invite

H. Zhong — researcher profile on SciRah

Yi-Zhuo Zhao×11

Invite

Yi-Zhuo Zhao — researcher profile on SciRah

Weimin Wang×11

Invite

Weimin Wang — researcher profile on SciRah

Invite

Y. Lou — researcher profile on SciRah

Invite

Wei Zhang — researcher profile on SciRah

Invite

Jie Shen — researcher profile on SciRah